RSH (so-called Smith-Lemli-Opitz) syndrome

Current Opinion in Pediatrics

Volumn 11, Issue 4, 1999, Pages 353-362

  Opitz, John M ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEHYDROCHOLESTEROL; SONIC HEDGEHOG PROTEIN;

CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE STRUCTURE; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SMITH LEMLI OPITZ SYNDROME; STEROL METABOLISM;

ANIMALS; GENES, RECESSIVE; GENETIC SCREENING; HUMANS; MICE; MUTATION; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PRENATAL DIAGNOSIS; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0032840521     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199908000-00015     Document Type: Review

References (60)

1. Smith SW, Lemli L, Opitz JM: A newly recognized syndrome of multiple congenital anomalies. J Pediatr 1964, 64:210-21.
2. Opitz JM, de la Cruz F: NICHD Conference: cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: cummary of an NICHD Conference. Am J Med Genet 1994, 50:326-338.
3. Irons M, Elias ER, Salen G, Tint GS, Batta AK: Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 1993, 341:1414.
4. Tint GS: Cholesterol defect in Smith-Lemli-Opitz syndrome. Am J Med Genet 1993, 47:573-574.
5. 5 Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G: Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. New Eng J Med 1994, 330:107-113.
6. Natowicz MR, Evans JE: Abnormal bile acids in the Smith Lemli-Opitz syndrome. Am J Med Genet 1994, 50:364-367.
7. Opitz JM: The RSH syndrome: paradigmatic metabolic malformation syndrome? In Diagnosis and Treatment of the Unborn Child. Edited by New MI. Reddick: Idelson-Gnocchi; 1999:43-55.
8. Curry CJ, Carey JC, Holland JS, Chopra D, Fineman R, Golabi M, et al.: Smith-Lemli-Opitz syndrome type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet 1987, 26:45-57.
9. Bialer MG, Penchaszadeh VB, Kahn E, Liber R, Krigsman G, Lesser ML: Female external genitalia and Müllerian duct derivatives in a 46,XY infant with the Smith-Lemli-Opitz syndrome. Am J Med Genet 1987, 28:723-731.
10. Lin AE, Ardinger HH, Ardinger RH, Cunniff C, Kelley RI: Cardiovascular malformations Smith-Lemli-Opitz syndrome. Am J Med Genet 1997, 68:270-278. This is the best review of heart defects in propositi with RSH syndrome.
11. Clark EB: Growth, morphogenesis, and function: the dynamics of cardiac development. In Fetal, Neonatal, and Infant Cardiac Disease. Edited by Moller JH, Meal WA. East Norwalk: Appleton & Lange; 1990:3-23.
12. DeJong G, Kirby PA, Muller LM: RSH (Smith-Lemli-Opitz) syndrome: "Severe" phenotype with ectrodactyly. Am J Med Genet 1998, 75:283-287.
13. Seller M, Russell J, Tint GS: Unusual case of Smith-Lemli-Opitz syndrome "type II". Am J Med Genet 1995, 56:265-268.
14. Ness GC, Lopez D, Borrego O, Gilbert-Barness E: Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. Am J Mad Genet 1997, 68:294-299
15. Pauli RM, Williams MS, Josephson KD, Tint GS: Smith-Lemli-Opitz syndrome: Thirty-year follow-up of "S" of "RSH" syndrome. Am J Med Genet 1997, 68:260-262.
16. Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J: Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am J Med Genet 1999, 82:382-384.
17. Nowaczyk MJM, Welan DT, Hill RE: Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. Am J Med Genet 1998, 78:419-423.
18. Andersson AJ, Stephan MJ, Walker WO, Kelley RI: Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism. Am J Med Genet 1998, 78:413-418.
19. Angle B, Tint GS, Yacoub OA, Clark AL: Atypical case of Smith-Lemli-Opitz syndrome: Implications for diagnosis. Am J Med Genet 1998, 80:322-326.
20. Cunniff C, Kratz LE, Moser A, Natowicz MR, Kelley RI: Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 1997, 68:263-269. This is an excellent review with clinical and biochemical correlations.
21. FitzPatrick DR, Keeling JW, Evans MJ, Kan AE, Bell JE, Porteous MEM, et al.: Clinical phenotype of desmosterolosis. Am J Med Genet 1998, 75:145-152. These authors provide a prototype description of desmosterolosis, a unique case to date.
22. Kelley RI, Wilcox WG, Smith M, Kratz LE, Moser A, Rimoin DL: Abnormal sterol metabolism in patients with Conradi-Hünermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. Am J Med Genet 1999, in press. These authors present the discovery of the inborn error of sterol metabolism in this form of skeletal dysplasia.
23. Chitayat D, Gruber H, Mullen BJ, Panzner D, Costa T, Lachman R, Rimoin RL: Hydrops-ectopic calcification moth-eaten skeletal dysplasia (Greenberg dysplasia): prenatal diagnosis and further delineation of a rare genetic disorder. Am J Mod Genet 1993, 47:272-277.
24. McGaughran JM, Clayton PT, Mills KA, Rimmer S, Moore L, Donnai D: Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995, 56:269-271.
25. Greenberg CR, Rimoin DL, Gruber HE, DeSa DJB, Reed M, Lachman RS: A new autosomal recessive lethal chondrodystrophy with congenital hydrops. Am J Med Genet 1988, 29:623-632.
26. Tint GS, Abuelo D, Till M, Cordier MP, Batta AK, Shefer S, et al.: Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn 1998, 18:651-658. This is an authoritative method for prenatal diagnosis.
27. Kratz LE, Kelley RI: Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 1999, 82:376-381. These authors provide an outstanding experience and analysis of prenatal diagnosis criteria.
28. Abuelo DN, Tint GS, Kelley RI, Batta AK, Shefer S, Salen G: Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am J Med Genet 1995, 56:281-285.
29. Donnai D, Young ID, Owen WG, Clark SA, Miller PFW, Knox WF: The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia and unilobar lungs. J Med Genet 1986, 23:64-71.
30. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH: Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995, 58:374-376.
31. McKeever PA, Young ID: Smith-Lemli-Opitz syndrome II: a disorder of the fetal adrenals. J Med Genet 1990, 27:465-466.
32. Rossiter JP, Hofman KJ, Kelley RI: Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Am J Med Genet 1995, 56:272-275.
33. Blitzer MG, Kelley RI, Schwartz MF: Abnormal maternal serum marker pattern associated with Smith-Lemli-Opitz (SLO) syndrome. Am J Hum Genet 1994, 55:277.
34. Bradley LA, Palomaki GE, Knight GJ, Haddow JE, Opitz JM, Irons M, et al.: Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet 1999, 82:355-358. These authors address the important issue of prenatal screening for RSH cases, especially in those that test screen-positive for 18-trisomy syndrome.
35. Moebius FF, Fitzky BU, Lee JN, Paik Y-K, Glossmann H: Molecular cloning and expression of the human Δ7-sterol reductase. Proc Natl Acad Sci U S A 1998, 95:1899-1902. This is the first publication on the genetic defect in RSH by the Innsbruck team.
36. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik Y-K, et al.: Mutations in the Δ7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A 1998, 95:8181-8186. This definitive paper by the Innsbruck group concerns the mutations in the 7- This definitive paper by the Innsbruck group concerns the mutations in the 7-DHCR gene in RSH syndrome.
37. Wassif CA, Maslen C, Kachilele-Linjewile S, Liu D, Linck LM, Connor WE, et al.: Mutations in the human sterol Δ7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 1998, 63:55-62. This is the National Institutes of Health team's first report on the 7-DHCR gene.
38. Waterham HR, Wijburg FA, Hennekam RCM, Vreken P, Poll-The BT, Dorland L, et al.: Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Med Genet 1998, 63:329-338. This is a report by the Dutch consortium on the 7-DHCR gene.
39. Lowry RB, Yong S-L: Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet 1980, 5:137-143.
40. Tsukahara M, Fujisawa K, Yamamoto K, Hasui M, Saito C, Yamamaka T, et al.: Smith-Lemli-Opitz syndrome in Japan. Am J Med Genet 1998, 75:118-119.
41. Kelley RI: RSH/Smith-Lemli-Opitz syndrome: Mutations and metabolic morphogenesis. Am J Med Genet 1998, 63:322-326. This is an authoritative review and commentary.
42. Johnson VP: Smith-Lemli-Opitz syndrome: review and report of two affected siblings. Z Kinderheilkd 1975, 119:221-234.
43. Kelley RI, Roessler E, Hennekam RC, Feldman GL, Kosaki K, Jones Mc, et al.: Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of sonic hedgehog? Am J Med Genet 1996, 66:478-484.
44. Alley TL, Gray BA, Lee SH, Scherer SW, Tsui LE, Tint GS, et al.: Identification of a yeast artificial chromosome clone spanning a translocation break point at 7q32.1 in a Smith-Lemli-Opitz patient. Am J Med Genet 56:1411-1416 [published erratum appears in Am J Med Genet 1995, 57:520-521.]
45. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, et al.: Identification of Sonic Hedgehog as a candidate gene responsible for holoprosencephaly. Nature Genet 1996, 14:353-356.
46. Porter JA, Young KE, Beachy PA: Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996, 274:255-259.
47. Porter JA, Ekker SC, Park WJ, von Kessler DP, Young KE, Chen CH, et al.: Hedgehog patterning activity: Role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. Cell 1996, 86:21-34.
48. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA: Cyclopia and defective axial patterning in mice lacking Sonic Hedgehog gene function. Nature 1996, 383:407-413.
49. Lanoue L, Dehart DB, Hinsdale ME, Maeda N, Tint GS, Sulik KK: Limb, genital, CNS, and facial malformations result from gene/enviroment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am J Med Genet 1997, 73:24-31. These authors report on the teratologic production of an RSH syndrome-like condition in mice engineered for lipoprotein-based cholesterol deficiency.
50. Cooper MK, Porter JA, Young KG, Beachy PA: Teratogen-mediated inhibition of target tissue response to SHH signaling. Science 1998, 280:1603-1607.
51. Tabin CJ, McMahon AP: Recent advances in hedgehog signaling. Trends Cell Biol 1997, 7:442-446.
52. Johnson RL, Scott MP: New players and puzzles in the Hedgehog signaling pathway. Curr Opinion Genet Dev 1998, 8:450-456.
53. Ding Q. Motoyama J, Gasca S, Mo R, Sasaki H, Rossaut J, Hui CC: Diminished sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development 125:2533-2543.
54. Motoyama J, Takabatake T, Takeshima K, Hui CC: Ptch2, a second mouse patched gene is co-expressed with sonic hedgehog. Nature Genet 1998, 18:104-106.
55. Ming JE, Roessler E, Muenke M: Human developmental disorders and the Sonic Hedgehog pathway. Mol Med Today 1998, 4:343-349. This is an excellent review.
56. Hammerschmidt M, Brook A, McMahon AP: The world according to hedgehog. Trends Genet 1997, 13:14-21. This is an excellent review.
57. Opitz JM, Yost HJ, Clark EB: Heart formation and developmental field theory. In Proceedings of the Fifth International Symposium on the Etiology and Morphogenesis of Congenital Heart Disease. In press, 1999.
58. Drenth JPH, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JGN, et al., and contributing members of the International Hyper-IgD Study Group: Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nature Genet 1999, 22:178-181.
59. Hauten SM, Kuis W, Duran M, deKoning TJ, van Royen-Kerkhof A, Romeijn GJ, et al.; Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinemia D and periodic fever syndrome. Nature Genet 1999, 22:175-177.
60. Liu XY, Dangel AW, Kelley RI, Zhao W, Denny P, Botcherby M, et al.: The gene mutated in bare patches and striated mice encodes a novel 3β-hydrosteroid dehydrogenase. Nature Genet 1999, 22:182-187.